a drug used decade treat psoriasis preventing halting rejection transplanted organs animals stanford university researcher said the compound tested human transplant patients pending approval us food drug administration said dr randall morris director stanfords laboratory transplant immunology the drug mycophenolic acid inhibits formation dna critical growth skin lesions common psoriasis researchers altered mycophenolic acid make easily absorbed body in altered form defuses dna process required white blood cells attack transplanted organs morris said